Evaluation of Glycemic Variability (GLAIVE)

NCT02812927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2026-06-15

No results posted yet for this study

Summary

This study compared two methods of insulin infusion by syringe pumps to assess the impact of medical devices on the glycaemic variability in patients under IIT in ICU. The main objective of the study was to show the superiority of the infusion system which permitted to dedicate a line for the insulin administration on the "standard" installation in terms of control of glycaemic variability.

Conditions

  • Critical Illness
  • Anesthesia

Interventions

DEVICE

Edelvaiss Multiline-8

Optimised infusion line

DEVICE

Standard infusion line

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Gilles Lebuffe, MD, PhD · University Hospital of Lille

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-07-31
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02812927 on ClinicalTrials.gov